TY - JOUR AU - Raghu, G. AU - Remy-Jardin, M. AU - Myers, J. L. AU - Richeldi, L. AU - Ryerson, C. J. AU - Lederer, D. J. PY - 2018 DA - 2018// TI - Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline JO - Am J Respir Crit Care Med VL - 198 UR - https://doi.org/10.1164/rccm.201807-1255ST DO - 10.1164/rccm.201807-1255ST ID - Raghu2018 ER - TY - JOUR AU - Nathan, S. D. AU - Shlobin, O. A. AU - Weir, N. AU - Ahmad, S. AU - Kaldjob, J. M. AU - Battle, E. PY - 2011 DA - 2011// TI - Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium JO - Chest VL - 140 UR - https://doi.org/10.1378/chest.10-2572 DO - 10.1378/chest.10-2572 ID - Nathan2011 ER - TY - JOUR AU - Natsuizaka, M. AU - Chiba, H. AU - Kuronuma, K. AU - Otsuka, M. AU - Kudo, K. AU - Mori, M. PY - 2014 DA - 2014// TI - Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences JO - Am J Respir Crit Care Med VL - 190 UR - https://doi.org/10.1164/rccm.201403-0566OC DO - 10.1164/rccm.201403-0566OC ID - Natsuizaka2014 ER - TY - JOUR AU - King, T. E. AU - Bradford, W. Z. AU - Castro-Bernardini, S. AU - Fagan, E. A. AU - Glaspole, I. AU - Glassberg, M. K. PY - 2014 DA - 2014// TI - A phase 3 trial of Pirfenidone in patients with idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402582 DO - 10.1056/NEJMoa1402582 ID - King2014 ER - TY - JOUR AU - Richeldi, L. AU - Bois, R. M. AU - Raghu, G. AU - Azuma, A. AU - Brown, K. K. AU - Costabel, U. PY - 2014 DA - 2014// TI - Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402584 DO - 10.1056/NEJMoa1402584 ID - Richeldi2014 ER - TY - JOUR AU - Kolb, M. AU - Bonella, F. AU - Wollin, L. PY - 2017 DA - 2017// TI - Therapeutic targets in idiopathic pulmonary fibrosis JO - Respir Med VL - 131 UR - https://doi.org/10.1016/j.rmed.2017.07.062 DO - 10.1016/j.rmed.2017.07.062 ID - Kolb2017 ER - TY - JOUR AU - Raghu, G. AU - Rochwerg, B. AU - Zhang, Y. AU - Garcia, C. A. AU - Azuma, A. AU - Behr, J. PY - 2015 DA - 2015// TI - An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis: an update of the 2011 clinical practice guideline JO - Am J Respir Crit Care Med VL - 192 UR - https://doi.org/10.1164/rccm.201506-1063ST DO - 10.1164/rccm.201506-1063ST ID - Raghu2015 ER - TY - JOUR AU - Raghu, G. AU - Collard, H. R. AU - Egan, J. J. AU - Martinez, F. J. AU - Behr, J. AU - Brown, K. K. PY - 2011 DA - 2011// TI - An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management JO - Am J Respir Crit Care Med VL - 138 UR - https://doi.org/10.1164/rccm.2009-040GL DO - 10.1164/rccm.2009-040GL ID - Raghu2011 ER - TY - JOUR AU - Bois, R. M. AU - Weycker, D. AU - Albera, C. AU - Bradford, W. Z. AU - Costabel, U. AU - Kartashov, A. PY - 2011 DA - 2011// TI - Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference JO - Am J Respir Crit Care Med VL - 184 UR - https://doi.org/10.1164/rccm.201105-0840OC DO - 10.1164/rccm.201105-0840OC ID - Bois2011 ER - TY - JOUR AU - Takahashi, H. AU - Sano, H. AU - Chiba, H. AU - Kuroki, Y. PY - 2006 DA - 2006// TI - Pulmonary surfactant proteins a and D: innate immune functions and biomarkers for lung diseases JO - Curr Pharm Des VL - 12 UR - https://doi.org/10.2174/138161206775474387 DO - 10.2174/138161206775474387 ID - Takahashi2006 ER - TY - JOUR AU - Kohno, N. AU - Kyoizumi, S. AU - Awaya, Y. AU - Fukuhara, H. AU - Yamakido, M. AU - Akiyama, M. PY - 1989 DA - 1989// TI - New serum Indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6 JO - Chest VL - 96 UR - https://doi.org/10.1378/chest.96.1.68 DO - 10.1378/chest.96.1.68 ID - Kohno1989 ER - TY - JOUR AU - Chiba, H. AU - Otsuka, M. AU - Takahashi, H. PY - 2018 DA - 2018// TI - Significance of molecular biomarkers in idiopathic pulmonary fibrosis: a mini review JO - Respir Investig VL - 56 UR - https://doi.org/10.1016/j.resinv.2018.06.001 DO - 10.1016/j.resinv.2018.06.001 ID - Chiba2018 ER - TY - JOUR AU - Takahashi, H. AU - Fujishima, T. AU - Koba, H. AU - Murakami, S. AU - Kurokawa, K. AU - Shibuya, Y. PY - 2000 DA - 2000// TI - Serum surfactant proteins a and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent JO - Am J Respir Crit Care Med VL - 162 UR - https://doi.org/10.1164/ajrccm.162.3.9910080 DO - 10.1164/ajrccm.162.3.9910080 ID - Takahashi2000 ER - TY - JOUR AU - Yokoyama, A. AU - Kondo, K. AU - Nakajima, M. AU - Matsushima, T. AU - Takahashi, T. AU - Nishimura, M. PY - 2006 DA - 2006// TI - Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis JO - Respirology VL - 11 UR - https://doi.org/10.1111/j.1440-1843.2006.00834.x DO - 10.1111/j.1440-1843.2006.00834.x ID - Yokoyama2006 ER - TY - JOUR AU - Ikeda, K. AU - Shiratori, M. AU - Chiba, H. AU - Nishikiori, H. AU - Yokoo, K. AU - Saito, A. PY - 2017 DA - 2017// TI - Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone JO - Respir Med VL - 131 UR - https://doi.org/10.1016/j.rmed.2017.08.021 DO - 10.1016/j.rmed.2017.08.021 ID - Ikeda2017 ER - TY - JOUR PY - 2002 DA - 2002// TI - ATS statement: guidelines for the six-minute walk test JO - Am J Respir Crit Care Med VL - 166 UR - https://doi.org/10.1164/ajrccm.166.1.at1102 DO - 10.1164/ajrccm.166.1.at1102 ID - ref16 ER - TY - JOUR AU - Noble, P. W. AU - Albera, C. AU - Bradford, W. Z. AU - Costabel, U. AU - Glassberg, M. K. AU - Kardatzke, D. PY - 2011 DA - 2011// TI - Articles Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomized trials JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60405-4 DO - 10.1016/S0140-6736(11)60405-4 ID - Noble2011 ER - TY - JOUR AU - Travis, W. D. AU - Costabel, U. AU - Hansell, D. M. AU - King, T. E. AU - Lynch, D. A. AU - Nicholson, A. G. PY - 2013 DA - 2013// TI - An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias JO - Am J Respir Crit Care Med VL - 188 UR - https://doi.org/10.1164/rccm.201308-1483ST DO - 10.1164/rccm.201308-1483ST ID - Travis2013 ER - TY - JOUR AU - Zhang, Y. AU - Kaminski, N. PY - 2012 DA - 2012// TI - Biomarkers in idiopathic pulmonary fibrosis JO - Curr Opin Pulm Med VL - 12 UR - https://doi.org/10.1097/MCP.0b013e328356d03c DO - 10.1097/MCP.0b013e328356d03c ID - Zhang2012 ER - TY - JOUR AU - Kinder, B. W. AU - Brown, K. K. AU - McCormack, F. X. AU - Ix, J. H. AU - Kervitsky, A. AU - Schwarz, M. I. PY - 2009 DA - 2009// TI - Serum surfactant protein-a is a strong predictor of early mortality in idiopathic pulmonary fibrosis JO - Chest VL - 135 UR - https://doi.org/10.1378/chest.08-2209 DO - 10.1378/chest.08-2209 ID - Kinder2009 ER - TY - JOUR AU - Takahashi, H. AU - Shiratori, M. AU - Kanai, A. AU - Chiba, H. AU - Kuroki, Y. AU - Abe, S. PY - 2006 DA - 2006// TI - Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D JO - Respirology VL - 11 UR - https://doi.org/10.1111/j.1440-1843.2006.00809.x DO - 10.1111/j.1440-1843.2006.00809.x ID - Takahashi2006 ER - TY - JOUR AU - Satoh, H. AU - Kurishima, K. AU - Ishikawa, H. AU - Ohtsuka, M. PY - 2006 DA - 2006// TI - Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases JO - J Intern Med VL - 260 UR - https://doi.org/10.1111/j.1365-2796.2006.01704.x DO - 10.1111/j.1365-2796.2006.01704.x ID - Satoh2006 ER - TY - JOUR AU - Wakamatsu, K. AU - Nagata, N. AU - Kumazoe, H. AU - Oda, K. AU - Ishimoto, H. AU - Yoshimi, M. PY - 2017 DA - 2017// TI - Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis JO - Respir Investig VL - 55 UR - https://doi.org/10.1016/j.resinv.2016.09.003 DO - 10.1016/j.resinv.2016.09.003 ID - Wakamatsu2017 ER - TY - JOUR AU - Sokai, A. AU - Tanizawa, K. AU - Handa, T. AU - Kanatani, K. AU - Kubo, T. AU - Ikezoe, K. PY - 2017 DA - 2017// TI - Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis JO - ERJ Open Res VL - 3 UR - https://doi.org/10.1183/23120541.00019-2016 DO - 10.1183/23120541.00019-2016 ID - Sokai2017 ER - TY - JOUR AU - Okuda, R. AU - Hagiwara, E. AU - Baba, T. AU - Kitamura, H. AU - Kato, T. AU - Ogura, T. PY - 2013 DA - 2013// TI - Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.06.011 DO - 10.1016/j.rmed.2013.06.011 ID - Okuda2013 ER - TY - JOUR AU - Martinez, F. J. AU - Flaherty, K. PY - 2006 DA - 2006// TI - Pulmonary Function Testing in Idiopathic Interstitial Pneumonias JO - Proc Am Thorac Soc VL - 3 UR - https://doi.org/10.1513/pats.200602-022TK DO - 10.1513/pats.200602-022TK ID - Martinez2006 ER - TY - JOUR AU - Zappala, C. J. AU - Latsi, P. I. AU - Nicholson, A. G. AU - Colby, T. V. AU - Cramer, D. AU - Renzoni, E. A. PY - 2010 DA - 2010// TI - Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis JO - Eur Respir J VL - 35 UR - https://doi.org/10.1183/09031936.00155108 DO - 10.1183/09031936.00155108 ID - Zappala2010 ER - TY - JOUR AU - Bois, R. M. AU - Weycker, D. AU - Albera, C. AU - Bradford, W. Z. AU - Costabel, U. AU - Kartashov, A. PY - 2011 DA - 2011// TI - Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference JO - Am J Respir Crit Care Med VL - 184 UR - https://doi.org/10.1164/rccm.201105-0840OC DO - 10.1164/rccm.201105-0840OC ID - Bois2011 ER - TY - JOUR AU - Nishikiori, H. AU - Chiba, H. AU - Ariki, S. AU - Kuronuma, K. AU - Otsuka, M. AU - Shiratori, M. PY - 2014 DA - 2014// TI - Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis JO - BMC Pulm Med VL - 14 UR - https://doi.org/10.1186/1471-2466-14-196 DO - 10.1186/1471-2466-14-196 ID - Nishikiori2014 ER - TY - JOUR AU - Günther, A. AU - Schmidt, R. AU - Nix, F. AU - Yabut-Perez, M. AU - Guth, C. AU - Rosseau, S. PY - 1999 DA - 1999// TI - Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis JO - Eur Respir J VL - 14 UR - https://doi.org/10.1034/j.1399-3003.1999.14c14.x DO - 10.1034/j.1399-3003.1999.14c14.x ID - Günther1999 ER - TY - JOUR AU - Kohno, N. AU - Awaya, Y. AU - Oyama, T. AU - Yamakido, M. AU - Akiyama, M. AU - Inoue, Y. PY - 2011 DA - 2011// TI - KL-6, a Mucin-like glycoprotein, in Bronchoalveolar lavage fluid from patients with interstitial lung disease JO - Am Rev Respir Dis VL - 148 UR - https://doi.org/10.1164/ajrccm/148.3.637 DO - 10.1164/ajrccm/148.3.637 ID - Kohno2011 ER - TY - JOUR AU - Oku, H. AU - Shimizu, T. AU - Kawabata, T. AU - Nagira, M. AU - Hikita, I. AU - Ueyama, A. PY - 2008 DA - 2008// TI - Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis JO - Eur J Pharmacol VL - 590 UR - https://doi.org/10.1016/j.ejphar.2008.06.046 DO - 10.1016/j.ejphar.2008.06.046 ID - Oku2008 ER - TY - JOUR AU - Gurujeyalakshmi, G. AU - Hollinger, M. A. AU - Giri, S. N. PY - 1999 DA - 1999// TI - Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level JO - Am J Phys VL - 276 UR - https://doi.org/10.1152/ajplung.1999.276.2.L311 DO - 10.1152/ajplung.1999.276.2.L311 ID - Gurujeyalakshmi1999 ER - TY - JOUR AU - Raghu, G. AU - Selman, M. PY - 2015 DA - 2015// TI - Nintedanib and Pirfenidone. New Antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions JO - Am J Respir Crit Care Med VL - 191 UR - https://doi.org/10.1164/rccm.201411-2044ED DO - 10.1164/rccm.201411-2044ED ID - Raghu2015 ER - TY - JOUR AU - Ikeda, S. AU - Sekine, A. AU - Baba, T. AU - Katano, T. AU - Tabata, E. AU - Shintani, R. PY - 2019 DA - 2019// TI - Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis JO - BMC Pulm Med VL - 19 UR - https://doi.org/10.1186/s12890-019-0841-7 DO - 10.1186/s12890-019-0841-7 ID - Ikeda2019 ER -